Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Researchers in Frankfurt, Germany, have described cell signaling events that occur when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells and have identified pathways that are essential for the virus to replicate.